IOVS
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


(Investigative Ophthalmology and Visual Science. 2006;47:4113-4120.)
© 2006 by The Association for Research in Vision and Ophthalmology, Inc.
DOI:  10.1167/iovs.06-0424

This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (10)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jacobson, S. G.
Right arrow Articles by MacDonald, I. M.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jacobson, S. G.
Right arrow Articles by MacDonald, I. M.

Remodeling of the Human Retina in Choroideremia: Rab Escort Protein 1 (REP-1) Mutations

Samuel G. Jacobson,1 Artur V. Cideciyan,1 Alexander Sumaroka,1 Tomas S. Aleman,1 Sharon B. Schwartz,1 Elizabeth A. M. Windsor,1 Alejandro J. Roman,1 Edwin M. Stone,2 and Ian M. MacDonald3

1From the Department of Ophthalmology, Scheie Eye Institute, University of Pennsylvania, Philadelphia, Pennsylvania; 2Howard Hughes Medical Institute and Department of Ophthalmology, University of Iowa Hospitals and Clinics, Iowa City, Iowa; and the 3Department of Ophthalmology, University of Alberta, Edmonton, Alberta, Canada.

PURPOSE. To characterize in detail the disease expression in choroideremia (CHM), a blinding X-linked disease of the retina caused by loss-of-function mutations in Rab Escort Protein 1 (REP-1). CHM is readily diagnosed in the clinic and by molecular testing but has lacked an animal model to test hypotheses and therapeutics. The recent report of a mouse model for CHM prompts the need for reassessment of the human disease in anticipation of treatment initiatives.

METHODS. CHM hemizygotes with REP-1 mutations, spanning an age range of 7 decades, were studied with in vivo microscopy by optical coherence tomography.

RESULTS. The disease expression was complex. Earliest stages involved a thickening of the retina that was otherwise normally laminated. Loss of photoreceptors, either independent or associated with retinal pigment epithelium (RPE) depigmentation, was followed by disorganization and further thickening of the retina with interlaminar bridges. The dysmorphic retina then slowly thinned over decades. Laminopathy occurred first in more peripheral rod-rich regions and later in the cone-rich fovea.

CONCLUSIONS. The CHM disease sequence involves detectable retinal thickening, which may be due to Müller cell activation and hypertrophy from photoreceptor stress. Photoreceptor degeneration, RPE depigmentation, and retinal remodeling follow. The results represent in vivo evidence in humans for retinal remodeling and provide a marker for the earliest stage of this response to genetic retinal disease. For CHM and other candidate human retinopathies considered for therapy, there is now a framework for making informed decisions about timing, retinal location, and potential value of treatment.





This article has been cited by other articles:


Home page
Hum Mol GenetHome page
S. G. Jacobson, A. V. Cideciyan, T. S. Aleman, A. Sumaroka, A. J. Roman, L. M. Gardner, H. M. Prosser, M. Mishra, N. T. Bech-Hansen, W. Herrera, et al.
Usher syndromes due to MYO7A, PCDH15, USH2A or GPR98 mutations share retinal disease mechanism
Hum. Mol. Genet., August 1, 2008; 17(15): 2405 - 2415.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
W. Herrera, T. S. Aleman, A. V. Cideciyan, A. J. Roman, E. Banin, T. Ben-Yosef, L. M. Gardner, A. Sumaroka, E. A. M. Windsor, S. B. Schwartz, et al.
Retinal Disease in Usher Syndrome III Caused by Mutations in the Clarin-1 Gene
Invest. Ophthalmol. Vis. Sci., June 1, 2008; 49(6): 2651 - 2660.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. S. Aleman, A. V. Cideciyan, A. Sumaroka, E. A. M. Windsor, W. Herrera, D. A. White, S. Kaushal, A. Naidu, A. J. Roman, S. B. Schwartz, et al.
Retinal Laminar Architecture in Human Retinitis Pigmentosa Caused by Rhodopsin Gene Mutations
Invest. Ophthalmol. Vis. Sci., April 1, 2008; 49(4): 1580 - 1590.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
T. S. Aleman, A. V. Cideciyan, A. Sumaroka, S. B. Schwartz, A. J. Roman, E. A. M. Windsor, J. D. Steinberg, K. Branham, M. Othman, A. Swaroop, et al.
Inner Retinal Abnormalities in X-linked Retinitis Pigmentosa with RPGR Mutations
Invest. Ophthalmol. Vis. Sci., October 1, 2007; 48(10): 4759 - 4765.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
S. G. Jacobson, T. S. Aleman, A. V. Cideciyan, E. Heon, M. Golczak, W. A. Beltran, A. Sumaroka, S. B. Schwartz, A. J. Roman, E. A. M. Windsor, et al.
Human cone photoreceptor dependence on RPE65 isomerase
PNAS, September 18, 2007; 104(38): 15123 - 15128.
[Abstract] [Full Text] [PDF]


Home page
Arch OphthalmolHome page
M. Mura, C. Sereda, M. M. Jablonski, I. M. MacDonald, and A. Iannaccone
Clinical and Functional Findings in Choroideremia Due to Complete Deletion of the CHM Gene
Arch Ophthalmol, August 1, 2007; 125(8): 1107 - 1113.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
B. L. Krock, J. Bilotta, and B. D. Perkins
Noncell-autonomous photoreceptor degeneration in a zebrafish model of choroideremia
PNAS, March 13, 2007; 104(11): 4600 - 4605.
[Abstract] [Full Text] [PDF]


Home page
IOVSHome page
S. G. Jacobson, A. V. Cideciyan, T. S. Aleman, A. Sumaroka, S. B. Schwartz, E. A. M. Windsor, A. J. Roman, E. Heon, E. M. Stone, and D. A. Thompson
RDH12 and RPE65, Visual Cycle Genes Causing Leber Congenital Amaurosis, Differ in Disease Expression
Invest. Ophthalmol. Vis. Sci., January 1, 2007; 48(1): 332 - 338.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 2006 by the Association for Research in Vision and Ophthalmology